News
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Although new medicines can help you lose weight faster and healthier than ever, a new psychology is needed to keep your ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results